Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|August 6, 2011
Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agentsThapi D Rao, Nestor Rosales, David R Spriggs
Plos One|May 13, 2015
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor InvasionThapi D Rao, Huasong Tian, Xun Ma, et al.
Molecular Cancer Therapeutics|April 12, 2022
Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective AgentsThapi D Rao, Mengyao Xu, Stephanie Eng, et al.
Molecular Cancer Therapeutics|September 5, 2021
Translational Strategies for Repotrectinib in NeuroblastomaTara J O'Donohue, Glorymar Ibáñez, Diego Ferreira Coutinho, et al.
ACS Chemical Biology|June 16, 2017
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer GrowthThapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, et al.
Med (New York, N.Y.)|October 4, 2022
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumorsDiego F Coutinho, Prabhjot S Mundi, Lianna J Marks, et al.
Molecular Cancer Therapeutics|September 5, 2025
Anti-tumor activity of trastuzumab deruxtecan in pediatric solid tumors with variable HER2 expressionChelsey M Burke, Tamar Y Feinberg, Samantha Brosius, et al.
Molecular Cancer Research : MCR|March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell TumorEmily K Slotkin, Anita S Bowman, Max F Levine, et al.
Cancer Research|July 2, 2026
A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic StrategiesFilemon S Dela Cruz, Daoqi You, Tamar Y Feinberg, et al.
Pageof 1